Province screening babies for spinal muscular atrophy
EDMONTON, AB – Muscular Dystrophy Canada is providing $366,000 to Alberta Precision Laboratories to implement the test through a one-year pilot program starting in early 2022.
This will make Alberta the second province in Canada to screen all newborns for spinal muscular atrophy so they can be treated earlier and more effectively.
Currently, Alberta’s Newborn Metabolic Screening Program screens newborns for 21 conditions.
Treatment for spinal muscular atrophy is most effective before the onset of symptoms.